<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: Statins Work Double Time Against Atrial Fibrillation</title>
	<atom:link href="http://medheadlines.com/2008/02/21/statins-work-double-time-against-atrial-fibrillation/feed/" rel="self" type="application/rss+xml" />
	<link>http://medheadlines.com/2008/02/21/statins-work-double-time-against-atrial-fibrillation/</link>
	<description>Medical news updated 24 hours</description>
	<pubDate>Fri, 19 Mar 2010 10:38:14 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Dr. James Harding</title>
		<link>http://medheadlines.com/2008/02/21/statins-work-double-time-against-atrial-fibrillation/comment-page-1/#comment-242</link>
		<dc:creator>Dr. James Harding</dc:creator>
		<pubDate>Sat, 23 Feb 2008 06:29:00 +0000</pubDate>
		<guid isPermaLink="false">http://medheadlines.com/2008/02/21/statins-work-double-time-against-atrial-fibrillation/#comment-242</guid>
		<description>A compound contained in red wine called resveratrol, discovered by Dr. Sinclair of Harvard, has been shown in peer reviewed studies to beneficially modulate the effects of statin drugs such as Lipitor and Zocor by approximately 55%. In studies of biotivia transmax, a lab grade concentrate of resveratrol used by reseachers, this compound also exhibited important neuroprotective effects against Alzheimers and Parkinsons disease. Resveratrol research could lead to a non-toxic and inexpensive treatment which operates at the gene level to intercept these diseases. Trials are currently underway at Colombia University and Woods Hole Institute as well as several European institutes on biotivia transmax and Dr. Sinclair is developing  a synthetic variation of it which will be sold as a prescription drug, if eventually approved by the FDA.</description>
		<content:encoded><![CDATA[<p>A compound contained in red wine called resveratrol, discovered by Dr. Sinclair of Harvard, has been shown in peer reviewed studies to beneficially modulate the effects of statin drugs such as Lipitor and Zocor by approximately 55%. In studies of biotivia transmax, a lab grade concentrate of resveratrol used by reseachers, this compound also exhibited important neuroprotective effects against Alzheimers and Parkinsons disease. Resveratrol research could lead to a non-toxic and inexpensive treatment which operates at the gene level to intercept these diseases. Trials are currently underway at Colombia University and Woods Hole Institute as well as several European institutes on biotivia transmax and Dr. Sinclair is developing  a synthetic variation of it which will be sold as a prescription drug, if eventually approved by the FDA.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
